Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial
- Resource Type
- Source
- The Lancet. 401:294-302
- Subject
General Medicine - Language
- ISSN
- 0140-6736